⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 10, 2024Current Medical Research and Opinion

Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study

Kadriye Bır Yucel Muzaffer Uğraklı Serhat Sekmek Nilgün Yıldırım Fatih Gürler Ozan Yazıcı Ahmet Özet Öznur Bal Murat Araz Mehmet Artaç Nuriye Özdemir

View at Publisher

Ask AI

Bookmark

Share

Abstract

Objective This study aimed to assess the efficacy and safety of FOLFIRI and paclitaxel in patients with advanced gastric cancer (AGC) who were previously treated with first-line modified docetaxel, cisplatin, 5-fluorouracil (mDCF), or 5-fluorouracil, oxaliplatin, docetaxel (FLOT).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yücel et al. (2024) studied this question.

synapsesocial.com/papers/68e65761b6db6435875e5fe7 https://doi.org/10.1080/03007995.2024.2366430

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Second-line Chemotherapy in Advanced Gastric Cancer: Taxanes versus 5-FU-Based TreatmentObservational Study · 2023 · 1 citations
2A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial2024 · 1 citations
3First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World AnalysisRetrospective Study · 2026
4Efficacy and Safety of First-Line Palliative Chemotherapy with Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel (FLOT) in HER2-Negative Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Institutional Real-World Experience from Eastern India2024 · 1 citations
5Outcomes of locally advanced gastric and gastroesophageal adenocarcinoma cancers treated with neoadjuvant FLOT in a tertiary care hospital in Pakistan2024 · 2 citations

The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer2024
Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116)2024
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospective study2024
Over-the-counter topical diclofenac in musculoskeletal pain: clinical value, access and responsible useCurrent Medical Research and Opinion · 2026
Cost-effectiveness of cladribine tablets for the treatment of active relapsing-remitting multiple sclerosis in the United KingdomCurrent Medical Research and Opinion · 2026

More from Current Medical Research and Opinion